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Abstract
In patients with acute coronary syndrome who were performed coronary arteries’ revascularization, in the postoperative
period disorders of hemodynamics and heart rate variability often develop. The aim of our work was to optimize the cardiac
rehabilitation of such patients by individualization of physical activity depending on the state of systolic and diastolic left
ventricular dysfunction and heart rate variability.
40 patients with acute coronary syndrome and coronary artery revascularization were included into the experimental group.
The control group consisted of 20 patients of the same age, clinical and laboratory manifestations of ACS who were treated
according to the protocol of Ministry of Health of Ukraine. In both groups of patients clinical efficacy of cardiac rehabilitation
process was evaluated according to the dynamics of clinical symptoms, systolic and diastolic left ventricular function and
heart rate variability.
In patients with acute coronary syndrome and coronary artery revascularization in the initial state the clinical and laboratory
signs of myocardial ischemia disappear, but subclinical and clinical manifestations of heart failure remain.
During the first month of training, the original accelerated cardiac rehabilitation program leads to the decrease of systolic and
diastolic signs of cardiac dysfunction and improves heart rate variability, which significantly improves the quality of life of
these patients.
For monitoring the efficacy and safety of the performance of cardiac rehabilitation program in patients with acute coronary
syndrome and coronary artery revascularization, in addition to conventional methods (determination of heart rate, blood
pressure, 6-minute test), it is useful to diagnose subclinical stage of heart failure by examination of systolic, diastolic function
and vegetative regulation.
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Problem statement and analysis of the
recent research
Acute coronary syndrome is considered to be a major cause
of cardiovascular mortality in the world [2, 11], thus, today
searching for the best treatment programs, including rehabili-
tation, for such category of patients is a priority [3]. Cardiac
rehabilitation is effective method of cardiac patients’ treat-
ment, who are recovering from acute cardiac heart disease
(myocardial infarction, unstable angina, acute heart failure),
surgical interventions and invasive procedures (revasculariza-
tion, heart and large vessels surgery) from a medical point
of view (effects on survival and quality of life) as well as
economically beneficial for health care system and society in
developed countries [5, 6, 8].
Today, evidence database on the effectiveness of cardiac
rehabilitation is quite big and shows that the complex cardiac
rehabilitation programs significantly reduce the mortality, risk
of development and progression of heart failure, recrudescent
hospitalizations, and necessity for revascularization and sig-
nificantly improve the quality of patients’ life [4.10]. It should
be noted that even during use of modern high-tech cardiac
surgical and pharmacological treatment, cardiac rehabilitation
significantly reduces above mentioned risks [12]. The mortal-
ity from cardiovascular diseases decreased by 20-30% due to
the introduction of rehabilitation and prophylactic programs
during last 30 years in Western Europe and the USA [7].
It is believed that the significant effect of cardiac rehabili-
tation on survival and life quality of patients with myocardial
infarction is mediated by several factors, including physiolog-
ical physical activity, psychological benefits of group support
and counseling, improved compliance of prophylactic therapy
and improved control of cardiovascular risks [9, 13]. Unfortu-
nately, even with such obvious advantages, the use of cardiac
rehabilitation is limited. Only about 25% of patients in the
United States are involved in such programs. In Ukraine, the
introduction of modern technologies and methods of cardiac
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rehabilitation are at an early stage [3, 4]. Rehabilitation pro-
grams for patients with acute coronary syndrome and coronary
arteries revascularization are not approved enough.
Therefore, the objective of our work was to optimize the
cardiac rehabilitation methods of patients with acute coronary
syndrome and coronary arteries revascularization by individu-
alization of physical activity depending on the state of systolic
and diastolic left ventricular dysfunction and heart rate vari-
ability.
1. Material and methods of research
40 patients with acute coronary syndrome (ACS) and coronary
artery revascularization (balloon angioplasty and placement
of a stent) were included into the experimental group. 25
(62.5%) patients were diagnosed ACS with ST-segment eleva-
tion according to the clinical protocol and recommendations
of the Expert Group of Ministry of Health of Ukraine (2017),
and 15 (37.5%) patients – ACS without ST-segment eleva-
tion. The average age of the examined patients was 52.6±6.7
years and ranged from 37 to 74 years. The control group
consisted of 20 patients with ACS of the same age, clini-
cal and laboratory manifestations, who were treated only by
medications: direct anticoagulants, dual antiplatelet therapy,
β -blockers, ACE inhibitors and statins. In patients of this
group cardio-surgical intervention has not been conducted
due to their written refusal. The groups were comparable of
age, sex, anthropometric indices and general clinical status.
Patients of the experimental group were divided into 2 sub-
groups. The first subgroup consisted of 21 (52.5%) patients
with ACS and cardiac revascularization in combination with
standard treatment and rehabilitation program according to the
protocols of the Ministry of Health of Ukraine. The second
subgroup included 19 (47.5%) patients with ACS and cardiac
revascularization in combination with standard treatment and
accelerated rehabilitation program [4]. The essence of this
program is that after the selection and stratification of patients’
risk, each participant was trained in the method of counting
the heart rate, self-monitoring of blood pressure and mea-
suring of the traveled distance. The program of accelerated
cardiac rehabilitation included eight degrees of increasing
physical activity (complex of exercises, walking, treadmill,
veloergometer). It was performed under the control and with
the help of the medical staff. The exercise correction was
performed after control of the components of the program
by analyzing clinical parameters (the presence and degree of
angina pectoris, breathlessness, data of heart rate and blood
pressure in calm and after a 6-minute walk test, ECG). Every
10-15 days the dynamics of biochemical parameters (lipido-
gram, glycemia, creatinine, ALT and AST) was performed.
The duration of the accelerated rehabilitation program was
from 2 to 4 weeks and depended on the functional class of the
patient. Monitoring of the therapy and cardiac rehabilitation
effectiveness was carried out 1 month after the beginning of
the program.
The diagnosis of myocardial infarction and the stage of
heart failure and indications for coronary arteries revascular-
ization were determined according to the recommendations of
the European Society of Cardiologists [11, 15]. The systolic
and diastolic functions of the left ventricle were evaluated by
Echo-CG (Philips HD11XE, the USA). EDD (end-diastolic
diameter), ESD (end-systolic diameter), EF (ejection fraction),
PAP (mean pulmonary artery pressure), and E (early diastolic
filling velocity), A (late diastolic filling velocity), E/A (the
ratio of the early (E) to late (A) ventricular filling velocities)
IVRT (isovolumic relaxation time), DT (deceleration time),
E’ (early diastolic velocity of the mitral annulus), E/e’ (ratio
of the early diastolic filling velocity to the early diastolic ve-
locity of the mitral annulus) were evaluated in Doppler mode.
HRV (heart rate variability) was assessed by Holter ECG on
the device CardioTens. The spectral parameters of HRV: TP
(total power), HF (high-frequency waves), LF (low-frequency
waves), LF/HF (ratio of low- to high-frequency component)
were evaluated.
2. Results and their discussions
In the initial state, in patients of both clinical groups, a sig-
nificant difference in the subjective complaints and objective
status was not recorded. It should be noted, that in patients of
both clinical groups in the initial state, the frequency of angina
pectoris symptoms and the necessity for short-acting nitrates
were not significantly different. The subjective complaints
were confirmed by the results of the instrumental examination,
which also showed a lack of reliable difference of initial state
between the left ventricular systolic, diastolic function and
autonomic regulation disorders in patients of both groups. At
the same time, the significant reduction in exercise tolerance
by the results of a 6-minute walking test in patients of both
groups was noted.
One month after the start of the treatment, the significant
improvement in the general clinical status according to the
subjective (life quality assessment), objective and laboratory-
instrumental research was noticed in patients with coronary
artery revascularization. In the experimental group of patients,
the self-esteem quality of life increased by 18.4%. These
patients did not feel unsatisfactory complaints, relapses of
angina pain or need of nitrates. At the same time, in a sig-
nificant proportion of examined patients of control group, a
decreased quality of life (80.0%), cardialgia or chest pain
(70.0%), palpitations (45.0%), sweating, breathlessness at
daily loads (35.0%) and general weakness (60.0%) were re-
mained.
In the initial state, in patients of the experimental and con-
trol groups a significant difference in change of left ventricular
systolic and diastolic function was not noticed. According to
the obtained data (Table 1), 1 month after initiation of treat-
ment, patients treated with accelerated rehabilitation program
had a positive dynamics in reducing the size of LA by 7.1%,
EDV by 13.9%, ESV by 16.0% and PAP by 16.8% compared
to patients treated by standard rehabilitation program, which
was accompanied by an increase of EF by 2.8% (> 0.05).
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Comparing the indicators of left ventricular systolic function
in patients treated with accelerated rehabilitation program
and the control group, the decreasement of the size of LA by
15.2%, EDV by 21.3%, ESV by 25.3% and PAP 30.9% was
noticed in 1 month from the beginning of treatment, which
was accompanied by an increase of EF by 6.2% (<0.05). At
the same time, in these patients, compared with the control
group, the E value significantly increased by 22.0% (Table 2).
In patients with ACS, who were treated by standard rehabil-
itation program, the E value increased by 12.0% (p> 0.05)
compared with the control group. Comparing the E value
between patients of the experimental group, it was found that
in patients of the second subgroup, the E rate was significantly
higher compared to patients in the first subgroup. Analyz-
ing changes of the A value after 1 month of treatment, it
was found that in patients in the first subgroup, this figure
increased by 12.5% compared with the control group. The A
value in patients of the second subgroup increased by 50.0%
compared with the control group and by 33.3% - compared
with patients in the first subgroup.
In 1 month after the start of treatment, the E/A ratio of
patients with ACS, who were treated by accelerated reha-
bilitation program decreased by 21.3% compared with the
control group and by 19.0% compared with patients of the
first subgroup. At the same time, the main role in differenti-
ation of the pseudonormal type of LVDD from the changes
in patients without LVDD was provided by the indicators of
tissue dopplerchocardiography and its combination with data
pulsed dopplechocardiography. As the disease progresses, the
velocity of the fibrous ring of the mitral valve E’ decreases
in the relaxation and pseudonormal type of LVDD, due to an
increase of the myocardium rigidity.
The E/E’ ratio in patients with relaxation type of LVDD
is less than 10, due to the decrease of E and E’ indexes, but in
patients with pseudonormal type of LVDD, this value is more
than 10. This is explained by the fact that the progression
of LVDD increases the pressure in the left atrium, and due
to this there is a pseudonormalization of the flows: the peak
E increases, but E’ decreases and for this reason ratio E/E’
increases. In our study in the examined patients of the second
subgroup the E’ significantly increased per 2.0 times, and in
patients in the first subgroup – per 1.5 times compared with
the control group in 1 month after the start of treatment. At the
same time, in patients with ACS who were treated by standard
rehabilitation program, the E/E’ ratio was 10.95±0.58, which
is characteristically for the pseudonormal type of LVDD. In
patients with ACS who were treated by for accelerated reha-
bilitation program, the E/E’ ratio was 8.69±0.23, which is
characteristically for relaxation type of LVDD.
After 1 month of therapy, in patients of the first and second
subgroups LVDD improved due to the significant increase-
ment of DT value by 5.5% and 16.8%, respectively, compared
with the control group. In patients of the first and second
subgroups, the IVRT value was also significantly higher (by
9.5% and by 27.9% respectively) compared with the control
group. The results of changes in left ventricular systolic and
diastolic function under the influence of cardiac rehabilitation
coincide with the data of world literature [1. 10].
Overall, after 1 month of treatment in 22 patients (55.0%)
of experimental group the relaxation type of LVDD was diag-
nosed and in 18 examined patients (45.0%) – pseudonormal
type. In patients of first subgroup relaxation type of LVDD
was diagnosed in 9 patients (42.9%) and pseudonormal – in
12 (57.1%). Among examined patients of the second sub-
group relaxation type of LVDD was diagnosed in 13 patients
(68.4%) and pseudonormal – in 6 patients (31.6%). The re-
sults, obtained in this research, indicate that use of accelerated
rehabilitation program in postoperative period in patients with
ACS and coronary arteries revascularization contributes to
more effective elimination of heart failure clinical manifes-
tations and disorders of left ventricular systolic and diastolic
function.
At the same time, in patients with ACS the functional state
of autonomic vegetative cardiac regulation is disturbed, which
leads to imbalance of sympathetic and parasympathetic effects
on the heart and can greatly influence the course of coronary
artery disease and development of subclinical heart failure. In
the initial state of the patients of both groups significant hyper-
sympathetic tone and increasement of sympatho-vagal index
(LF/HF) were noted, which leads to inhibition of vegetative
regulation and a decreasement of TP (Table. 3).
One month after the start of treatment, the Holter moni-
toring of the ECG was re-examined for all patients. In com-
parison with baseline data, in patients with ACS who were
treated with accelerated rehabilitation program, a significant
increase of TP was found, as compared with the control group
(by 25.6%) and with patients who were treated with a standard
rehabilitation program (by 14.2%). In patients of the second
subgroup the LF value was significantly higher (by 42.3%)
compared with the control group and by 24.6% higher com-
pared with patients who were treated with standard rehabili-
tation program. In control group, the HF value growth more
slowly, which indicated an increasement of the sympatho-
vagal index compared with baseline data. In patients of the
second subgroup, this value was by 1.7 times higher than in
patients of control group and by 1.5 times higher, compared
with the patients of the first subgroup. The obtained data indi-
cate a significant increase of parasympathetic influences on
cardiac muscle in patients who were treated with accelerated
rehabilitation program.
One month after complex drug therapy and accelerated
rehabilitation program, the sympatho-vagal index (LF/HF)
was lower in patients of the experimental group compared
with control due to the more rapid growth of HF value. In
patients of the second subgroup, LF/HF value was signifi-
cantly lower (by 28.2%) compared with the control group and
by 19.6% lower compared to the first subgroup of patients.
These changes indicate a decrease of hypersympathetic tone
in patients of second subgroup.
The control methods used in this trial for improving the
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Table 1. Data of left ventricular systolic function in the examined patients (M±m)
Indicator Control group Standard rehabilitationprogram
Accelerated
rehabilitation program p1-2 p1-3 p2-3
n = 20 n = 21 n = 19
PAP, mm Hg 1 35.45±0.83 36.43±1.25 34.84±1.33 >0.05 >0.05 >0.052 33.00±0.80 27.38±0.81 22.79±0.87 <0.01 <0.01 <0.01
LA, sm 1 4.43±0.09 4.46±0.08 4.49±0.11 >0.05 >0.05 >0.052 4.81±0.06 4.39±0.05 4.08±0.05 <0.01 <0.01 <0.01
EDV, ml 1 158.55±3.04 161.86±3.61 159.21±2.81 >0.05 >0.05 >0.052 171.80±2.28 157.05±1.36 135.21±1.66 <0.01 <0.01 <0.01
ESV, ml 1 87.45±1.61 88.43±2.05 88.53±1.47 >0.05 >0.05 >0.052 94.60±1.57 84.10±1.06 70.68±1.47 <0.01 <0.01 <0.01
EF, % 1 44.49±1.38 45.26±0.85 44.08±1.38 >0.05 >0.05 >0.052 44.87±0.80 46.38±0.79 47.66±1.07 >0.05 <0.05 >0.05
Notes:
p1-2 – the reliability of data differences in patients with a standard rehabilitation program comparing with the control group;
p1-3 – the reliability of data differences in patients with an accelerated rehabilitation program comparing with the control group;
p2-3 – the reliability of data differences in patients with the standard rehabilitation program comparing with the accelerated rehabilitation
program;
1 – indicators at first day of hospitalization;
2 – indicators after 1 month of treatment.
Table 2. Data of left ventricular diastolic function in examined patients (M±m)
Indicator Control group Standard rehabilitationprogram
Accelerated
rehabilitation program p1-2 p1-3 p2-3
n = 20 n = 21 n = 19
E, sm/s 1 0.56±0.02 0.54±0.02 0.55±0.02 >0.05 >0.05 >0.052 0.50±0.01 0.56±0.02 0.61±0.01 <0.05 <0.01 <0.05
A, sm/s 1 0.53±0.02 0.50±0.02 0.52±0.03 >0.05 >0.05 >0.052 0.48±0.02 0.54±0.01 0.72±0.02 <0.05 <0.01 <0.01
E/A 1 1.12±0.07 1.09±0.04 1.11±0.08 >0.05 >0.05 >0.052 1.08±0.05 1.05±0.05 0.85±0.02 >0.05 <0.01 <0.05
E’, sm/s 1 0.04±0.01 0.03±0.01 0.03±0.01 >0.05 >0.05 >0.052 0.03±0.01 0.05±0.01 0.07±0.01 >0.05 <0.05 >0.05
E/E’ 1 22.05±3.36 19.16±1.85 20.03±2.08 >0.05 >0.05 >0.052 21.98±3.05 10.95±0.58 8.69±0.23 <0.01 <0.01 <0.01
DT, ms 1 197.30±3.21 190.19±1.85 199.36±2.87 >0.05 >0.05 >0.052 185.40±2.82 195.52±2.52 216.53±1.61 <0.05 <0.01 <0.01
IVRT, ms 1 96.55±1.28 94.14±1.82 98.32±1.33 >0.05 >0.05 >0.052 90.20±2.10 98.76±1.74 115.35±2.80 <0.01 <0.01 <0.01
Notes:
p1-2 – the reliability of data differences in patients with a standard rehabilitation program comparing with the control group;
p1-3 – the reliability of data differences in patients with an accelerated rehabilitation program comparing with the control group;
p2-3 – the reliability of data differences in patients with the standard rehabilitation program comparing with the accelerated rehabilitation
program;
1 – indicators at first day of hospitalization;
2 – indicators after 1 month of treatment.
effectiveness of the original cardiac rehabilitation program
in patients with ACS, undergoing coronary artery revascu-
larization (hemodynamic and vegetative cardiac regulation
changes), proved the aim of the research and allowed to cor-
rect the drug therapy and program of rehabilitation in time. In
postoperative patients with ACS, the use of accelerated reha-
bilitation program has shown its priority in terms of clinical
status restoring, decreasing of heart failure functional class,
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Table 3. Data of heart rate variability in the examined patients with ACS (M±m)
Indicator Control group Standard rehabilitationprogram
Accelerated
rehabilitation program p1-2 p1-3 p2-3
n = 20 n = 21 n = 19
TP,ms2
1 2242.20±123.21 2369.95±113.51 2299.11±118.10 >0.05 >0.05 >0.05
2 2794.80±108.53 3074.05±139.03 3510.16±124.52 >0.05 <0.01 <0.05
LF,ms2
1 765.80±86.20 857.10±67.44 816.26±75.28 >0.05 >0.05 >0.05
2 1019.80±62.26 1166.62±99.28 1453.11±86.08 >0.05 <0.01 <0.05
HF,ms2
1 428.10±59.20 414.38±44.25 431.79±42.38 >0.05 >0.05 >0.05
2 526.10±58.96 604.86±64.97 941.32±75.79 >0.05 <0.01 <0.01
LF/HF 1 2.10±0.22 2.15±0.13 2.11±0.16 >0.05 >0.05 >0.052 2.34±0.23 2.09±0.11 1.68±0.11 >0.05 <0.05 <0.05
Notes:
p1-2 – the reliability of data differences in patients with a standard rehabilitation program comparing with the control group;
p1-3 – the reliability of data differences in patients with an accelerated rehabilitation program comparing with the control group;
p2-3 – the reliability of data differences in patients with the standard rehabilitation program comparing with the accelerated rehabilitation
program;
1 – indicators at first day of hospitalization;
2 – indicators after 1 month of treatment.
normalization of left ventricular systolic, diastolic function
and sympatho-vagal index.
3. Conclusions
1. In the initial state in patients with acute coronary syn-
drome, who were treated by coronary arteries revascu-
larization, clinical and laboratory-instrumental signs of
myocardial ischemia disappear, but clinical and subclin-
ical manifestations of heart failure remain.
2. During the first month of treatment the use of accel-
erated rehabilitation program leads to a decrease of
systolic and diastolic dysfunction symptoms and im-
provement of heart rate variability, which significantly
increases the life quality of these patients.
3. For the effectiveness and safety of cardiac rehabilitation
in patients with acute coronary syndrome, who were
treated by coronary artery revascularization, in addition
to the generally accepted methods (determination of
heart rate, blood pressure, a 6-minute test), it is advis-
able to diagnose the subclinical stage of heart failure
by evaluating the left ventricular systolic and diastolic
function and the state of heart rate variability.
4. Prospects for further research
Improvement of the rehabilitation method of patients with
acute coronary syndrome who were treated by coronary artery
revascularization, which will improve the life quality of this
category of patients.
References
[1] Ryiding E. Echocardiography: Practical Guide.
MEDpress-inform; 2010.
[2] Vatutin NT, Kalinkina NV, Shevelek AN, Adarychev VV.
Chronic heart failure due to ischemic heart disease. Heart
failure. 2010; 2:95-106.
[3] Shved MI, Levytska LV. Modern strategies of treatment
and rehabilitation of patients with myocardial infarction.
Kyiv: Medicine;2 015.
[4] Shved MI, Levytska LV. Modern technologies and meth-
ods of cardiac rehabilitation. Kyiv: Medicine; 2016.
[5] Oldridge NB, Guyatt GH, Fischer ME, Rimm AA. Car-
diac rehabilitation after myocardial infarction. Combined
experience of randomized clinical trials. JAMA. 1988;
260:945-950. DOI: https://doi.org/10.1001/
jama.1988.03410070073031 [PMid:3398199]
[6] Leon AS, Franklin BA, Costa F, et al. Cardiac rehabilita-
tion and secondary prevention of coronary heart disease:
an American Heart Association scientific statement from
the Council on Clinical Cardiology (Subcommittee on
Exercise, Cardiac Rehabilitation, and Prevention) and the
Council on Nutrition, Physical Activity, and Metabolism
(Subcommittee on Physical Activity), in collaboration
with the American Association of Cardiovascular and
Pulmonary Rehabilitation. Circulation. 2005; 111: 369 -
376. DOI: https://doi.org/10.1161/01.CIR.
0000151788.08740.5C [PMid:15668354]
[7] Suaya JA, Stason WB, Ades PA, Normand SL, Shep-
ard DS. Cardiac rehabilitation and survival in older
Cardiorehabilitation of Patients with Acute Coronary Syndrome Who Were Performed Coronary Arteries
Revascularization — 6/6
coronary patients. J. Am. Coll. Cardiol. 2009; 54: 25-
33. DOI: https://doi.org/10.1016/j.jacc.
2009.01.078 [PMid:19555836]
[8] Stewart KJ, Badenhop D, Brubaker PH, Keteyian SJ,
King M. Cardiac rehabilitation following percutaneous
revascularization, heart transplant, heart valve surgery,
and for chronic heart failure. Chest. 2003; 123:2104-
2111. DOI: https://doi.org/10.1378/chest.
123.6.2104 [PMid:12796195]
[9] Lavie CJ, Thomas RJ, Squires RW, Allison TG, Milani
RV. Exercise training and cardiac rehabilitation in pri-
mary and secondary prevention of coronary heart disease.
Mayo Clin. Proc. 2009;84: 373-383. DOI: https://
doi.org/10.1016/S0025-6196(11)60548-X
[10] Taylor RS, Brown A, Ebrahim S, et al. Exercise-
based rehabilitation for patients with coronary heart
disease: systematic review and metaanalysis of ran-
domized controlled trials. Am. J. Med. 2004; 116:
682-692. DOI: https://doi.org/10.1016/j.
amjmed.2004.01.009 [PMid:15121495]
[11] Ponikowski P, Voors AA, Anker SD, et al. Guide-
lines for the diagnosis and treatment of acute and
chronic heart failure. European Heart Journal. 2016;
37:2129-2200. DOI: https://doi.org/10.1093/
eurheartj/ehw128 [PMid:27206819]
[12] Goel Kashish, Lennon Ryan J, Tilbury R Thomas,
Squires Ray W, Thomas Randal J. Impact of Car-
diac Rehabilitation on Mortality and Cardiovascular
Events After Percutaneous Coronary Intervention
in the Community. Circulation. 2011; 123:2344-
2352. DOI: https://doi.org/10.1161/
CIRCULATIONAHA.110.983536 [PMid:21576654]
[13] Marchionni N, Fattirolli F, Fumagalli S et al. Improved
exercise tolerance and quality of life with cardiac reha-
bilitation of older patients after myocardial infarction:
results of a randomized, controlled trial. Circulation.
2003;107:2201-2206. DOI: https://doi.org/
10.1161/01.CIR.0000066322.21016.4A
[PMid:12707240]
[14] Otto C. Textbook of clinical echocardiography. 3- rd ed. -
LSVR SAUNDERS; 2004.
[15] Ibanez Borja, James Stefan, Agewall Stefan et al. 2017
ESC Guidelines for the management of acute myocardial
infarction in patients presenting with ST-segment eleva-
tion: The Task Force for the management of acute my-
ocardial infarction in patients presenting with ST-segment
elevation of the European Society of Cardiology (ESC).
European Heart Journal. 2017; 00:1-66.
Received: 26 May 2017
Revised: 10 Oct 2017
Accepted: 23 Oct 2017
